Jewish Hospital & St Mary's Healthcare Acute Care Hospital (Medicare Certified) Location: 200 Abraham Flexner Way, Louisville, Kentucky 40202 Ratings: Phone: (502) 587-4011 |
Norton Hospitals, Inc Acute Care Hospital (Medicare Certified) Location: 200 East Chestnut Street, Louisville, Kentucky 40202 Ratings: Phone: (502) 629-8000 |
Baptist Health Louisville Acute Care Hospital (Medicare Certified) Location: 4000 Kresge Way, Louisville, Kentucky 40207 Ratings: Phone: (502) 897-8100 |
University Of Louisville Hospital Acute Care Hospital (Medicare Certified) Location: 530 South Jackson Street, Louisville, Kentucky 40202 Ratings: Phone: (502) 562-3000 |
The Brook Hospital - Dupont Psychiatric Hospital (Medicare Certified) Location: 1405 Browns Lane, Louisville, Kentucky 40207 Ratings:NA Phone: (502) 896-0495 |
The Brook Hospital - Kmi Psychiatric Hospital (Medicare Certified) Location: 8521 Lagrange Road, Louisville, Kentucky 40242 Ratings:NA Phone: (502) 426-6380 |
Central State Hospital Psychiatric Hospital (Medicare Certified) Location: 10510 Lagrange Road, Louisville, Kentucky 40223 Ratings:NA Phone: (502) 253-7045 |
News Archive
Young adults often experiment with hard drugs, such as cocaine, amphetamines and opiates, and all but about 10 percent stop as they assume adult roles and responsibilities. Those still using hard drugs into their 50s are five times more likely to die earlier than those who do not, according to a new study by University of Alabama at Birmingham researchers published online Jan. 27, 2012, in the Journal of General Internal Medicine.
Without sleep, the emotional centers of the brain dramatically overreact to negative experiences, reveals a new brain imaging study in the October 23rd issue of Current Biology, a publication of Cell Press.
Hospitals, health insurers and patients often rely on patient death rates in hospitals to compare hospital quality. Now a new study by researchers at Yale School of Medicine questions the accuracy of that widely used approach and supports measuring patient deaths over a period of 30 days from admission even after they have left the hospital.
A new study presented at the Experimental Biology Annual Meeting shows that a proprietary blend extracted from canola, Dermytol, produces a pronounced reduction of malignant melanoma cell growth. Dermytol, a proprietary compound developed by KGK Synergize Inc., a biotechnology company in Ontario Canada, is designed to protect skin cells from damage that may lead to skin cancer.
› Verified 9 days ago